FD-274

N/A

Report date: 2023/10/17 14:21:43
NME

Base Information

Drug NameFD-274
Drug Alias NameFD-274FD274
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsPI3-kinase class I inhibitors
TargetsSerine/threonine-protein kinase mTORPI3-kinase class I
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesFudan University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A